drugset
drugset / Trial / NCT03226431

Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0

NCT03226431 ↗

Phase 1 Completed 6 enrolled Duke University
NaSingle-groupOpen-labelTreatment

Summary

To treat an intermediate size patient population of bilateral lung transplant patients with CLAD-0.

Timeline

Start
2017-12-11
Primary completion
2019-06-25
Completion
2019-06-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified 88 mg/ml Inhaled

Indications

No indication recorded.